MedTrace Logo

Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis

NCT03506152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2018-04-24

No results posted yet for this study

Summary

Procalcitonin is a promising marker of sepsis in critically ill patients. Procalcitonin have better diagnostic accuracy compared to White blood cell count and C - reactive protein. Investigators propose that adding Procalcitonin to the list of standard laboratory work up of critically ill patients with suspected sepsis could increase diagnostic accuracy leading to better patient care.

Conditions

Interventions

DIAGNOSTIC_TEST

Serum Procalcitonin

Seven ml of blood was drawn in gel separator tubes within 24 hours of admission in ICU for Procalcitonin determination

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2015-12-03
Completion
2015-12-03

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03506152 on ClinicalTrials.gov